Showing results (1751-1760 of 1,770) with videos related to

Sort By:
Pageof 177
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
JAMA Dermatology|April 24, 2024
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus StatementMcKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 1, 2019
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationNicholas T Olney, Elise Ong, Sheng-Yang M Goh, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2019
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degenerationAdam M Staffaroni, Yann Cobigo, Sheng-Yang M Goh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Hepatology (Baltimore, Md.)|October 16, 2025
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Neurology|April 8, 2021
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar DegenerationJulio C Rojas, Ping Wang, Adam M Staffaroni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpointAdam M Staffaroni, Lynn Bajorek, Kaitlin B Casaletto, et al.
Gastroenterology|October 15, 2020
Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 SubjectsXingyi Guo, Weiqiang Lin, Wanqing Wen, et al.
Pageof 177